Researchers are testing stem cells from umbilical cord for the prevention of brain injuries in premature babies.

A team of researchers from Monash University in Australia is conducting a clinical study called 'The ALLO Trial' to evaluate the effectiveness of stem cells harvested from umbilical cord blood in preventing brain injuries in premature newborns. These babies are at risk of severe neurological conditions, including cerebral palsy.

The study is based on previous research that has demonstrated the safety and feasibility of using stem cells from the newborns' own umbilical cord.

Umbilical cord stem cells have anti-inflammatory and immunomodulatory properties, essential for protecting the developing brain tissue.

Researchers are optimistic that if the therapy proves effective, it could become a new standard of care for premature infants, improving their neurological development.